600276 fundamentals
An in-depth look to JIANGSU HENGRUI PHARMACEUTICALS CO operating, investing, and financing activities
600276 free cash flow for Q1 25 is -128.07 M CNY. For 2024, 600276 free cash flow was 5.51 B CNY and operating cash flow was 7.48 B CNY.
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25